全球基于价值的医疗保健市场规模、份额和趋势分析报告 – 行业概况和 2031 年预测

基于价值的医疗保健市场分析

全球价值型医疗保健市场正在迅速发展，其驱动力是转向改善患者治疗效果和提高整体护理质量。最近的发展表明，医疗保健提供者、付款人和患者越来越多地采用价值型护理模式，特别是针对不断上涨的医疗成本和对患者满意度的更多重视。远程医疗和数字健康解决方案等创新正在融入价值型护理框架，从而可以实时监控患者的健康状况并制定更加个性化的治疗计划。例如，使用数据分析和人工智能来识别患者需求和优化治疗途径正在获得越来越多的关注，从而改善临床结果。此外，医疗保健提供者和技术公司之间正在建立合作伙伴关系，以创建促进协调护理服务的综合护理管理平台。此外，医疗保健提供者和技术公司之间正在建立合作伙伴关系，以创建促进协调护理服务的综合护理管理平台。随着世界各国政府和监管机构推广基于价值的报销模式，市场增长预计将加速。这种转变强调了对人口健康管理和预防保健的日益关注，最终目标是在控制成本和改善患者体验的同时提供更高质量的护理。

基于价值的医疗保健市场规模

2023 年全球基于价值的医疗保健市场规模价值为 101.7 亿美元，预计到 2031 年将达到 428.8 亿美元，2024 年至 2031 年预测期内的复合年增长率为 19.7%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

基于价值的医疗保健市场趋势

“不断提高数据驱动决策的整合程度”

The value-based healthcare market is witnessing a significant trend towards data-driven decision-making, which enhances patient outcomes while reducing costs. Healthcare providers are increasingly leveraging big data analytics to identify population health trends, tailor treatment plans, and measure clinical outcomes effectively. For instance, value based healthcare companies  like Mount Sinai Health System have implemented predictive analytics to assess patient risk factors, allowing for proactive interventions that improve health outcomes. Such approach enhances the quality of care and aligns with value-based care principles by ensuring that resources are allocated efficiently. In addition, the integration of Electronic Health Records (EHRs) with advanced analytics platforms enables healthcare providers to track patient progress over time, fostering continuous improvement in treatment strategies. As more healthcare systems adopt these data-driven methodologies, the demand for value-based care solutions is expected to rise, ultimately contributing to a more effective and patient-centered healthcare landscape.

Report Scope and Value-Based Healthcare Market Segmentation    

Value-Based Healthcare Market Definition

Value-based healthcare is a healthcare delivery model that prioritizes patient outcomes and the overall value of care rather than the volume of services provided. In this approach, healthcare providers are incentivized to focus on delivering high-quality care that improves patient health, enhances the patient experience, and reduces overall healthcare costs. The model emphasizes the importance of measuring outcomes, such as recovery rates and patient satisfaction, alongside the cost of care. By aligning financial incentives with the quality of care delivered, value-based healthcare aims to create a more efficient and effective healthcare system that benefits patients, providers, and payers alike.

Value-Based Healthcare Market Dynamics

Drivers

• Rising Healthcare Costs

Rising healthcare costs are a significant catalyst driving the shift towards value-based care models, as stakeholders seek to improve cost efficiency while enhancing patient outcomes. According to the Centers for Medicare & Medicaid Services (CMS), U.S. healthcare spending is projected to exceed USD 6 trillion by 2027, highlighting the unsustainable nature of the traditional fee-for-service model, which incentivizes volume over quality. In response, many healthcare providers are adopting value-based care strategies that prioritize quality metrics and patient satisfaction, thereby reducing unnecessary expenditures associated with avoidable hospitalizations and complications. Such focus on delivering high-quality care improves patient health outcomes and promotes more efficient resource allocation, enabling healthcare systems to deliver better care at lower costs. As a result, driving market growth.

• Growing Government Supportive Initiatives and Policies

Government initiatives and policies play a crucial role in advancing value-based healthcare by implementing frameworks that incentivize quality care over quantity. In the U.S., programs such as the Medicare Value-Based Purchasing Program have established a payment model that ties reimbursements to the quality of care delivered rather than the volume of services provided. For instance, under the Hospital Value-Based Purchasing (HVBP) Program, hospitals can earn financial bonuses for meeting specific performance measures related to patient outcomes and satisfaction. Such performance measures include metrics such as readmission rates, patient experience scores, and clinical process improvements. As a result, hospitals are increasingly motivated to enhance care quality and improve patient outcomes to secure these incentives, leading to a broader adoption of value-based models throughout the healthcare system, ultimately driving the market growth.

Opportunities

• Increasing  Technological Advancements

Technological advancements are pivotal in facilitating the implementation of value-based care, as innovations such as electronic health records (EHRs), telemedicine, and data analytics enable healthcare providers to track patient outcomes more effectively and coordinate care efficiently. EHRs, for instance, streamline access to patient information, allowing providers to analyze treatment effectiveness and monitor adherence to clinical guidelines in real-time.  The COVID-19 pandemic accelerated telehealth adoption, with a 1700% increase in telehealth visits in March 2020 compared to the previous year. As such technologies continue to evolve, they will further empower healthcare providers to deliver high-quality, cost-effective care, ultimately creating opportunities in the market.

• Rising Prevalence of Chronic Diseases

The value-based healthcare market is poised for significant growth due to the constantly rising prevalence of chronic diseases and physical disabilities, which drive the adoption of innovative care models that emphasize patient outcomes over volume of services. According to the World Health Organization (WHO), chronic diseases, including heart disease, diabetes, and respiratory conditions, account for approximately 71% of all deaths globally, underscoring the urgent need for effective management strategies. As the aging population grows, the demand for personalized and efficient healthcare solutions will intensify. Such demographic shift propels healthcare providers to transition from traditional fee-for-service models to value-based care, which incentivizes improved health outcomes and cost-efficiency. Consequently, stakeholders can leverage these trends to innovate care delivery, enhance patient engagement, and ultimately create oportunities within the value-based healthcare market.

Restraints/Challenges

• High Upfront Implementation Costs

Upfront implementation costs represent a significant barrier to the adoption of value-based care initiatives, particularly for smaller healthcare providers and organizations. The transition from traditional fee-for-service models to value-based care requires substantial investments in technology, infrastructure, and workforce training to effectively track patient outcomes and manage care coordination. For instance, implementing electronic health records (EHR) systems and analytics tools to monitor patient data can cost thousands of dollars, which may be financially unfeasible for independent clinics or small practices with limited budgets. Such financial strain can deter many providers from pursuing value-based care models, ultimately limiting access to innovative care delivery approaches that aim to improve patient outcomes and reduce costs in the long term.

• Diverse Regulatory Compliances

Regulatory hurdles significantly complicate the implementation of value-based care models, as varying reimbursement policies and frameworks across countries create inconsistencies in care delivery. For instance, in the United States, Medicare, Medicaid, and private insurers each have different reimbursement criteria, making it challenging for providers to navigate diverse requirements. Such fragmentation can discourage healthcare organizations from fully adopting value-based care, as uncertainties regarding alignment with regulations persist. In contrast, countries like the U.K. have more unified approaches, yet even there, regional variations can hinder consistent care delivery. These regulatory discrepancies affects providers willingness to embrace value-based care and lead to uneven patient experiences, ultimately compromising care quality across regions.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Value-Based Healthcare Market Scope

The market is segmented on the basis of model, deployment, platform, and application. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Model

• Accountable Care Organization (ACO)
• Patient-centered Medical Home (PCMH)
• Pay for Performance (P4P)
• Bundled Payments

Deployment

• Cloud-Based
• On-Premise

Platform

• Standalone
• Integrated

Application

• Hospitals
• Clinics
• Insurance Companies
• Government

Value-Based Healthcare Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, model, deployment, platform, and application as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the value-based healthcare market, primarily driven by an increase in healthcare reforms aimed at improving patient outcomes and reducing overall costs. These reforms include initiatives that incentivize providers to deliver high-quality care rather than focusing solely on the volume of services rendered. In addition, the growing emphasis on population health management and accountability among healthcare stakeholders further supports the region's dominance in adopting value-based care models.

Asia-Pacific region is projected to experience substantial growth from 2024 to 2031, driven by a variety of factors. The increasing awareness among the population regarding health issues, coupled with enhancements in healthcare infrastructure, is expected to play a crucial role in this growth trajectory. In addition, the overall improvement in the population's health outlook will further support the demand for healthcare services and products, contributing to the market's expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Value-Based Healthcare Market Share

市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。

在市场上运营的基于价值的医疗保健市场领导者是：

• Koninklijke Philips NV（荷兰）
• 液化空气集团（法国）
• 日本医疗研究开发机构（日本）
• 苹果公司（美国）
• ThemeArile（美国）
• DaVita Inc.（美国）
• Diaverum AB（瑞典）
• 家庭保健公司（美国）
• 家庭医疗保健解决方案有限公司（美国）
• Knight Health Holdings, LLC（美国）
• LHC Group, Inc.（美国）
• Portea Medical（印度）
• 欧姆龙株式会社（日本）
• B. Braun Medical Inc.（德国）
• BPL MEDICAL SAS（印度）
• 康德乐 (美国)

基于价值的医疗保健市场的最新发展

• 2023 年 4 月，凯撒基金会医院和 Geisinger Health 宣布成立 Risant Health，这是一家非营利组织，旨在推动涵盖多个付款人和提供者的各种社区医疗系统中的价值型护理。该计划旨在通过促进各利益相关方之间的合作并改善患者治疗效果来增强医疗保健服务
• 2023 年 2 月，明尼苏达州蓝十字蓝盾与 Homeward 合作建立了全风险价值型护理安排，专门针对改善明尼苏达州农村地区的医疗服务可及性，从而解决医疗服务不足地区的医疗保健差距

SKU-67757